Dong-Dong Lin Selected Research

Dong-Dong Lin Research Topics

3	Neoplasms (Cancer) 01/2023 - 12/2018
2	Infections 10/2020 - 03/2019
2	Fibrosis (Cirrhosis) 03/2019 - 01/2019
2	Reinfection 01/2019 - 01/2014
2	Hepatitis B 01/2019 - 01/2014
2	End Stage Liver Disease 01/2014 - 08/2013
1	Adenocarcinoma 04/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020
1	Liver Neoplasms (Liver Cancer) 08/2020
1	Hepatocellular Carcinoma (Hepatoma) 08/2020
1	Lung Neoplasms (Lung Cancer) 08/2019
1	Neoplasm Metastasis (Metastasis) 08/2019
1	Chronic Hepatitis B 03/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Portal Hypertension 01/2019
1	Oligodendroglioma 12/2018
1	Astrocytoma (Pilocytic Astrocytoma) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2018
1	Acute-On-Chronic Liver Failure 08/2013

2	Biomarkers (Surrogate Marker)IBA 03/2019 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2014
2	hepatitis B hyperimmune globulinIBA 01/2019 - 01/2014
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 04/2024
1	Dual-Specificity PhosphatasesIBA 01/2023
1	alexidineIBA 01/2023
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2022
1	Cytochrome P-450 CYP3AIBA 02/2022
1	saxagliptin FDA Link 02/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020
1	gadolinium ethoxybenzyl DTPA FDA Link 08/2020
1	MicroRNAs (MicroRNA)IBA 03/2019
1	nasIBA 01/2019
1	NucleotidesIBA 01/2019
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2019
1	Laminin (Merosin)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	Collagen Type IV (Type IV Collagen)IBA 01/2019
1	enasidenibIBA 08/2018
1	Antiviral Agents (Antivirals)IBA 01/2014
1	NucleosidesIBA 01/2014
1	BilirubinIBA 08/2013